The Efficacy of Tomosynthesis in the BIRADS 3 Population Including Surveillance of Patients in the Treatment or Post-Treatment for Breast Cancer
Inclusion Criteria:
GROUP 1
- female of any race and ethnicity
- 35 years or older
- after routine and diagnostic imaging, subject is categorized as a BI-RADS 3 and will
undergo study imaging within 30 days of routine or diagnostic imaging.
- subject is returning for surveillance imaging after a categorization of a BI-RADS 3
and will undergo study imaging within 30 days of surveillance imaging GROUP 2
- female of any race and ethnicity
- 26 years or older
- subject has completed cancer treatment and is currently categorized as a BI-RADS 3
for surveillance imaging
- subject will undergo study imaging within 30 days of surveillance imaging GROUP 3
- female of any race and ethnicity
- 26 years or older
- subject is currently undergoing cancer treatment and is currently categorized as a
BI-RADS 3 for surveillance imaging OR
- subject will undergo study imaging within 30 days of surveillance imaging
Exclusion Criteria:
- GROUP 1, 2 and 3
- subjects unable or unwilling to participate
- subjects who are unable or unwilling to tolerate compression
- subjects who are pregnant or who think they may be pregnant
- subjects who are breastfeeding